New Century Healthcare Holding Co. Limited
HKEX:1518.HK
0.93 (HKD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 933.073 | 636.459 | 632.565 | 512.785 | 729.369 | 615.984 | 536.46 | 490.933 | 258.196 | 249.013 | 238.77 |
| Cost of Revenue
| 525.986 | 434.317 | 433.83 | 377.021 | 468.067 | 378.409 | 278.177 | 247.921 | 117.686 | 105.118 | 88.981 |
| Gross Profit
| 407.087 | 202.142 | 198.735 | 135.764 | 261.302 | 237.575 | 258.283 | 243.012 | 140.51 | 143.895 | 149.789 |
| Gross Profit Ratio
| 0.436 | 0.318 | 0.314 | 0.265 | 0.358 | 0.386 | 0.481 | 0.495 | 0.544 | 0.578 | 0.627 |
| Reseach & Development Expenses
| 5.93 | 7.695 | 10.574 | 14.467 | 3.831 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 129.882 | 131.828 | 156.429 | 123.269 | 146.626 | 114.469 | 79.48 | 102.318 | 38.312 | 34.702 | 32.883 |
| Selling & Marketing Expenses
| 68.268 | 62.286 | 60.811 | 44.068 | 44.201 | 30.614 | 21.032 | 19.003 | 10.612 | 11.278 | 7.272 |
| SG&A
| 198.15 | 194.114 | 217.24 | 167.337 | 190.827 | 145.083 | 100.512 | 121.321 | 48.924 | 45.98 | 40.155 |
| Other Expenses
| 0.002 | 3.292 | 3.661 | 3.782 | 1.025 | 0.545 | -0.797 | -0.612 | -0.238 | -0.186 | -0.07 |
| Operating Expenses
| 202.128 | 201.809 | 227.814 | 181.804 | 194.658 | 145.083 | 99.715 | 120.709 | 48.686 | 45.794 | 40.085 |
| Operating Income
| 171.809 | -20.283 | -25.411 | -46.04 | 62.625 | 96.91 | 172.95 | 175.024 | 91.711 | 98.051 | 109.661 |
| Operating Income Ratio
| 0.184 | -0.032 | -0.04 | -0.09 | 0.086 | 0.157 | 0.322 | 0.357 | 0.355 | 0.394 | 0.459 |
| Total Other Income Expenses Net
| -29.95 | -269.57 | -33.736 | -282.707 | -14.56 | 22.366 | -13.032 | 51.795 | 0.16 | 2.597 | 1.044 |
| Income Before Tax
| 166.142 | -289.853 | -59.147 | -328.747 | 48.065 | 119.276 | 159.918 | 174.098 | 91.984 | 100.698 | 110.748 |
| Income Before Tax Ratio
| 0.178 | -0.455 | -0.094 | -0.641 | 0.066 | 0.194 | 0.298 | 0.355 | 0.356 | 0.404 | 0.464 |
| Income Tax Expense
| 34.053 | 1.72 | 26.115 | 48.787 | 43.572 | 45.838 | 45.031 | 37.137 | 24.789 | 26.383 | 28.038 |
| Net Income
| 84.164 | -291.573 | -85.262 | -377.534 | 4.493 | 73.438 | 114.887 | 98.635 | 40.903 | 46.705 | 53.566 |
| Net Income Ratio
| 0.09 | -0.458 | -0.135 | -0.736 | 0.006 | 0.119 | 0.214 | 0.201 | 0.158 | 0.188 | 0.224 |
| EPS
| 0.17 | -0.6 | -0.18 | -0.78 | 0.009 | 0.15 | 0.24 | 0.35 | 0.16 | 0.18 | 0.2 |
| EPS Diluted
| 0.17 | -0.6 | -0.18 | -0.78 | 0.009 | 0.15 | 0.24 | 0.11 | 0.14 | 0.16 | 0.18 |
| EBITDA
| 267.336 | 49.966 | 61.21 | -186.155 | 179.697 | 153.797 | 178.28 | 144.18 | 96.838 | 103.433 | 112.842 |
| EBITDA Ratio
| 0.287 | 0.079 | 0.097 | -0.363 | 0.246 | 0.25 | 0.332 | 0.294 | 0.375 | 0.415 | 0.473 |